American Century Companies Inc Chinook Therapeutics, Inc. Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.66 - $38.58 $1,679 - $3,472	-90 Reduced 0.59%	15,060 $578,000
Q1 2023 May 11, 2023	BUY	$21.53 - $26.8 $5,942 - $7,396	276 Added 1.86%	15,150 $350,000
Q4 2022 Feb 13, 2023	BUY	$18.63 - $27.35 $85,791 - $125,946	4,605 Added 44.84%	14,874 $389,000
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $179,810 - $239,986	10,269 New	10,269 $202,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.